These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The past, present and future of stem cell clinical trials for ALS. Thomsen GM; Gowing G; Svendsen S; Svendsen CN Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827 [TBL] [Abstract][Full Text] [Related]
10. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS). Haidet-Phillips AM; Maragakis NJ Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754 [TBL] [Abstract][Full Text] [Related]
11. Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Suzuki M; Svendsen CN Trends Neurosci; 2008 Apr; 31(4):192-8. PubMed ID: 18329734 [TBL] [Abstract][Full Text] [Related]
12. The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy - a perspective on cell biological mechanisms. Tang BL Rev Neurosci; 2017 Oct; 28(7):725-738. PubMed ID: 28599400 [TBL] [Abstract][Full Text] [Related]
13. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946 [TBL] [Abstract][Full Text] [Related]
14. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients. Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608 [TBL] [Abstract][Full Text] [Related]
15. Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Lunn JS; Sakowski SA; Feldman EL Stem Cells; 2014 May; 32(5):1099-109. PubMed ID: 24448926 [TBL] [Abstract][Full Text] [Related]